Page last updated: 2024-08-16

vesnarinone and carbostyril

vesnarinone has been researched along with carbostyril in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashida, W; Kawai, C; Kumada, T1
Feldman, AM; Strobeck, JE1
Young, JB1
Bertolet, BD1
Piao, HR; Wu, Y1

Reviews

4 review(s) available for vesnarinone and carbostyril

ArticleYear
[New oral drugs for the treatment of congestive heart failure].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:2

    Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol

1992
Quinolinone derivatives in the management of congestive heart failure.
    Coronary artery disease, 1994, Volume: 5, Issue:2

    Topics: Animals; Cardiotonic Agents; Heart Failure; Humans; Pyrazines; Quinolines; Quinolones

1994
Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies.
    Drug safety, 2004, Volume: 27 Suppl 1

    Topics: Animals; Clinical Trials as Topic; Death, Sudden; Heart Failure; Humans; Monitoring, Physiologic; Multicenter Studies as Topic; Neutropenia; Pyrazines; Quinolines; Quinolones

2004
The progress towards the development of DHQO derivatives and related analogues with inotropic effects.
    Mini reviews in medicinal chemistry, 2013, Volume: 13, Issue:12

    Topics: Animals; Cardiotonic Agents; Pyrazines; Quinolines; Quinolones; Rabbits; Stroke Volume; Structure-Activity Relationship

2013

Other Studies

1 other study(ies) available for vesnarinone and carbostyril

ArticleYear
The best of times, the worst of times: the wealth and poverty of heart failure pharmacotherapies: is there a role for vesnarinone?
    Drug safety, 2004, Volume: 27 Suppl 1

    Topics: Clinical Trials as Topic; Drug Therapy; Forecasting; Heart Failure; Humans; Pyrazines; Quinolines; Quinolones; Socioeconomic Factors; Time Factors

2004